December 2025 Summaries

Gartner's "Market Guide for Enterprise AI Search" emphasizes the role of generative AI in improving internal productivity through AI-driven knowledge access, focusing on governance and compliance in employee-centric applications. However, the guide does not adequately address the distinct needs of customer-facing AI search applications, where performance, low-latency, and personalization are crucial for enhancing user experience and business outcomes. Unlike enterprise systems that prioritize policy compliance and internal productivity, customer-facing applications require high-volume, low-latency retrieval systems with sophisticated ranking and multimodal capabilities, impacting revenue and engagement directly. Vespa is highlighted as a solution tailored for such environments, providing real-time, scalable retrieval and ranking for companies like Spotify and Yahoo, designed for AI-native systems rather than retrofitted enterprise search.

Retrieval-Augmented Generation (RAG) systems often grapple with a precision-latency trade-off, but this can be mitigated through a combination of multiphase ranking, layered retrieval, and semantic chunking. Multiphase ranking employs a staged approach to scoring, starting with lightweight filters and progressing to more advanced machine learning models, ensuring precision while managing latency and compute costs. Layered retrieval balances the need for fine-grained and whole-document retrieval by selecting the most relevant documents and then narrowing down to key chunks, optimizing signal-to-noise ratios for downstream processing. Semantic chunking further enhances retrieval quality by breaking documents into meaningful segments, reducing noise and improving recall and precision. These techniques form a robust retrieval stack that improves the accuracy and efficiency of RAG systems, as exemplified by Vespa's architecture, which integrates these strategies to deliver low-latency, high-precision results at scale.

AI search platforms are gaining prominence as user expectations for search evolve from simply returning accurate results to performing complex tasks such as answering questions, summarizing research, and solving problems. This shift is propelled by the rapid maturation of generative AI, which is categorized into three levels of complexity: chatbots, deep research, and agentic systems. Advanced AI search platforms combine traditional search techniques with modern AI, using vector and tensor search, full-text search, multistep ranking, and real-time inference to deliver precise and scalable results. These platforms are crucial for enterprises aiming to maintain competitiveness in customer-facing applications, as they provide the speed, scale, and accuracy required for demanding use cases. As basic vector search capabilities become insufficient for more complex tasks, AI search platforms are emerging as the backbone of AI-driven business and are essential for enterprises seeking to lead in this new era.

In the fifth installment of a series summarizing a panel discussion from the Fierce Pharma Webinar, industry leaders from Novo Nordisk, Alkermes, and Harvard Medical School highlight the growing importance of approaching artificial intelligence in life sciences as a search and retrieval challenge rather than focusing on building larger models. The discussion emphasizes that efficient AI applications in healthcare and pharmaceuticals depend on retrieving the right context consistently, as search processes are integral to various stages of the value chain, from drug discovery to patient cohort analysis and member journey tracking. Vespa.ai is identified as a pivotal engine driving this shift toward smarter retrieval systems, wherein context is regarded as the key currency. The conversation advocates for designing AI with a focus on retrieval to enhance intelligence, marking a departure from the traditional emphasis on expanding large language models.

In the fourth part of a series on life sciences AI, Harini Gopalakrishnan discusses the importance of smarter data retrieval in healthcare, emphasizing the need for unified multimodal data systems to enhance clinical decision-making. Dr. Salim Afshar from Harvard Medical School highlights that the richest insights in healthcare arise from the intersection of structured, unstructured, and imaging data, which are crucial for distinguishing conditions like lung cancer subtypes. The discussion emphasizes that AI should support clinicians by organizing complex data rather than dictating care. The article also addresses challenges for healthcare payers, noting that personalization is limited by siloed data and suggesting that AI-driven retrieval and similarity search could personalize care plans by learning from patient contexts. The session concludes with a demonstration of Biocanvas, a retrieval engine built on Vespa.ai, capable of quickly matching patients to clinical trials using a shared tensor space for multimodal data, showcasing how this technology can transform months of manual work into minutes.

The December 2025 edition of the Vespa newsletter highlights numerous updates and enhancements aimed at improving retrieval quality, ranking flexibility, and developer productivity. Key updates include automated Approximate Nearest Neighbor (ANN) tuning for quicker and more precise retrieval, accelerated exact vector distance computations using Google Highway for faster search operations, and enhanced proximity queries with a more expressive NEAR operator. Additional improvements involve precise chunk-level matching, on-the-fly tensor creation from structs for ranking, and simpler rank-profile management through inner profiles, all contributing to more accurate and efficient data processing. Furthermore, JSONL support in streaming visiting facilitates large-scale data processing, while new content such as webinars, articles, and ebooks provide resources and insights for optimizing Vespa's capabilities in search and AI applications. These updates collectively offer businesses improved application performance, reduced operational costs, and enhanced retrieval and ranking systems.

In the context of the life sciences industry, the future of Generative AI (GenAI) lies in smarter data retrieval rather than merely building larger models, particularly in the commercial and marketing sectors. Harini Gopalakrishnan, during a presentation at a Fierce Pharma Webinar, emphasized the need for AI to focus on effective information retrieval to provide relevant insights tailored to various commercial personas like healthcare professionals and brand managers. Anubhav Srivastava from Novo Nordisk highlighted the importance of viewing commercial AI as a human-centric search task, using Retrieval-Augmented Generation (RAG) to efficiently manage vast amounts of unstructured data. As AI solutions scale, maintaining performance and trust becomes a challenge, especially when dealing with complex documents. The integration of personalization, perception, people, and performance are crucial factors for success, drawing inspiration from search-focused companies like Spotify. The ultimate goal is to adapt retrieval processes to suit different user needs while ensuring sustained performance and realistic expectations of AI capabilities.

In the second part of a five-part series on the future of AI in life sciences, Harini Gopalakrishnan discusses the shift in focus from building larger AI models to smarter search and retrieval methods, particularly in pharmaceutical research and development. During a panel discussion with leaders from Novo Nordisk, Alkermes, and Harvard Medical School, the conversation highlighted how drug discovery is increasingly viewed as a search problem due to the vast combinatorial space of molecules and proteins. By using tensor embeddings to represent complex relationships between chemical, biological, and textual data, researchers can significantly narrow down the search space, making the drug discovery process more efficient and explainable. This approach contrasts with traditional knowledge graphs by allowing dynamic relationship inference and real-time graph construction, thus enhancing the retrieval and predictive capabilities of AI models in life sciences.

The article outlines a panel discussion from the Fierce Pharma x Vespa.ai event, highlighting the shift in the life sciences sector, where AI is increasingly viewed as a search and retrieval problem rather than merely building larger models. This perspective emphasizes the importance of retrieval-augmented generation (RAG) systems, which focus on retrieving, ranking, and contextualizing information to enhance the performance of large language models, particularly in regulated industries like healthcare. The discussion underscores that the success of AI in this field hinges on the precision of information retrieval, which directly impacts the trustworthiness and accuracy of AI-generated responses. By drawing on the expertise of search-first companies like Perplexity and Spotify, the article illustrates how advanced retrieval solutions, such as phased ranking, can improve the reliability and scalability of AI applications in health and life sciences. This approach allows models to access and utilize specific, relevant data, thereby reducing inaccuracies and increasing trust in AI outputs.